期刊文献+

哪些非酒精性脂肪性肝炎-肝癌动物模型更具实用价值? 被引量:2

Which animal models of nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC) have more practical value in experimental investigations?
原文传递
导出
摘要 非酒精性脂肪性肝病(NAFLD)曾被认为只在进展到肝硬化后才发生肝癌,新近的临床研究表明NAFLD在脂肪性肝炎(NASH)期就可出现肝癌.NAFLD的流行及其恶变率的升高要求尽早阐明肝细胞癌(HCC)的发病机制,评估新颖治疗的效果,这需要可靠的动物模型.现总结具有实用价值的NASH-HCC模型的特点,希望利用这些模型揭开NASH-HCC的神秘面纱. In the past,we used to think that hepatocellular carcinoma (HCC) only occurred when nonalcoholic fatty liver disease (NAFLD) progressed to liver cirrhosis.However,recent clinical studies have shown that HCC may occur during the stage of nonalcoholic steatohepatitis (NASH).The prevalence of NAFLD and the increasing incidence of NASH-associated HCC require the elucidation of the pathogenesis of NASH-HCC and the assessment of the efficacy of novel therapies as early as possible,while these evaluations need reliable animal models.This article reviews the characteristics of NASH-HCC models with a practical value to uncover the mysteries of NASH-HCC.
作者 段娜娜 吴健
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2016年第3期230-233,共4页 Chinese Journal of Hepatology
基金 国家自然科学基金(81272436,81572356) 复旦大学吴健教授启动基金
关键词 非酒精性脂肪性肝病 非酒精性脂肪性肝炎相关肝癌 动物模型 Non-alcoholic fatty liver disease (NAFLD) Nonalcoholic steatohepatitis-associatedhepatocellular carcinoma (NASH-HCC) Animal models
  • 相关文献

参考文献24

  • 1Noureddin M,Mato JM,Lu SC.Nonalcoholic fatty liver disease:update on pathogenesis,diagnosis,treatment and the role of S-adenosylmethionine[J].Exp Biol Med (Maywood).2015,240(6):809-820.DOI:10.1177/1535370215579161.
  • 2Rozman D.From nonalcoholic Fatty liver disease to hepatocellular carcinoma:a systems understanding[J].Dig Dis Sci,2014,59(2):238-241.DOI:10.1007/s 10620-013-2998-x.
  • 3Ozturk Y,Soylu OB.Fatty liver in childhood[J].World J Hepatol,2014,6(1):33-40.DOI:10.4254/wjh.v6.i1.33.
  • 4Imajo K,Yoneda M,Kessoku T,et al.Rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis[J].Int J Mol Sci,2013,14(11):21833-21857.DOI:10.3390/ijms141121833.
  • 5Hebbard L,George J.Animal models of nonalcoholic fatty liver disease[J].Nat Rev Gastroenterol Hepatol,2011,8(1):35-44.DOI:10.1038/nrgastro.2010.191.
  • 6Schattenberg JM,Galle PR.Animal models of non-alcoholic steatohepatitis:of mice and man[J].Dig Dis,2010,28(1):247-254.DOI:10.1159/000282097.
  • 7Maher JJ.New insights from rodent models of fatty liver disease[J].Antioxid Redox Signal,2011,15(2):535-550.DOI:10.1089/ ars.2010.3749.
  • 8Willebrords J,Pereira IV,Maes M,et al.Strategies,models and biomarkers in experimental non-alcoholic fatty liver disease research[J].Prog Lipid Res,2015,59:106-125.DOI:10.1016/ j.plipres.2015.05.002.
  • 9Adkins Y,Schie IW,Fedor D,et al.A novel mouse model of nonalcoholic steatohepatitis with significant insulin resistance[J].Lab Invest,2013,93(12):1313-1322.DOI:10.1038/labinvest.2013.123.
  • 10Dowman JK,Hopkins LJ,Reynolds GM,et al.Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle[J].Am J Pathol,2014,184(5):1550-1561.DOI:10.1016/j.ajpath.2014.01.034.

同被引文献6

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部